Top Page
De.mem Ltd.
(Sydney:DEM)
De.mem Ltd. (DEM) vs. iShares MSCI Australia ETF (EWA)
De.mem Ltd. Business Overview & Revenue Model
De.mem Ltd. Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.19M | 24.90M | 23.41M | 19.64M | 18.08M | 14.16M |
| Gross Profit | 11.40M | 10.16M | 8.39M | -521.00K | -1.54M | 3.68M |
| EBITDA | -40.00K | -1.01M | -1.23M | -1.70M | -2.93M | -2.75M |
| Net Income | -2.05M | -2.77M | -3.13M | -3.49M | -4.47M | -3.54M |
Balance Sheet | ||||||
| Total Assets | 19.48M | 20.58M | 18.70M | 20.56M | 22.05M | 11.22M |
| Cash, Cash Equivalents and Short-Term Investments | 3.93M | 3.72M | 2.47M | 5.39M | 8.82M | 5.08M |
| Total Debt | 1.21M | 1.37M | 1.65M | 1.40M | 1.64M | 562.44K |
| Total Liabilities | 7.57M | 7.66M | 7.13M | 6.25M | 7.67M | 4.51M |
| Stockholders Equity | 11.91M | 12.92M | 11.57M | 14.31M | 14.35M | 6.71M |
Cash Flow | ||||||
| Free Cash Flow | 1.08M | -10.00K | -2.23M | -3.65M | -3.73M | -2.00M |
| Operating Cash Flow | 1.13M | 115.00K | -1.45M | -1.88M | -2.31M | -1.16M |
| Investing Cash Flow | -674.00K | -1.22M | -728.00K | -3.97M | -4.31M | -1.35M |
| Financing Cash Flow | -1.53M | 2.28M | -485.00K | 2.32M | 10.54M | -544.06K |
De.mem Ltd. Technical Analysis
De.mem Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | AU$55.95M | 12.40 | 20.77% | 4.55% | 66.80% | 625.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | AU$188.45M | 19.69 | 7.04% | 2.95% | 4.52% | -31.16% | |
53 Neutral | AU$18.34M | -2.84 | -25.77% | ― | 4.84% | -12.12% | |
50 Neutral | AU$32.66M | -14.29 | -16.00% | ― | 11.53% | 46.15% | |
50 Neutral | AU$11.24M | -4.09 | -26.47% | ― | -45.80% | -210.00% | |
48 Neutral | AU$102.86M | -4.04 | ― | ― | 11.44% | 19.49% |
De.mem Ltd. Corporate Events
De.mem Ltd has disclosed a change in director Andreas Hendrik De Wit’s holdings following his participation in a company share placement. The director acquired 2,380,952 fully paid ordinary shares at $0.105 per share, increasing his direct holding in the company, while his existing options position remains unchanged. The new shares were issued as part of a placement to fund the acquisition of Core Chemicals Pty Ltd, a transaction previously announced and approved by shareholders, underscoring the director’s financial backing of the capital raising and aligning his interests more closely with the company’s growth strategy.
The most recent analyst rating on (AU:DEM) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on De.mem Ltd. stock, see the AU:DEM Stock Forecast page.
De.mem Limited has issued 2,380,952 fully paid ordinary shares at $0.105 per share to its chairman, Andreas Hendrik De Wit, following shareholder approval at a recent general meeting, as part of the funding package for its previously announced acquisition of Core Chemicals Pty Ltd. The company has confirmed that the shares were issued without a prospectus under the relevant Corporations Act provisions and that it remains compliant with its continuous disclosure and financial reporting obligations, with no excluded information requiring disclosure, thereby facilitating secondary trading of the new shares and underlining its adherence to regulatory standards during its expansion efforts.
The most recent analyst rating on (AU:DEM) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on De.mem Ltd. stock, see the AU:DEM Stock Forecast page.
De.mem Ltd has applied to the ASX for quotation of 2,380,952 new fully paid ordinary shares, issued on 22 January 2026 under a previously announced transaction. The additional stock will increase the company’s free float and share liquidity once admitted to trading, modestly expanding its capital base and potentially broadening its investor reach.
The most recent analyst rating on (AU:DEM) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on De.mem Ltd. stock, see the AU:DEM Stock Forecast page.
De.mem reported record cash receipts of about $8.8 million for the December 2025 quarter, up 19% on the prior corresponding period, marking its highest quarterly result and extending its run to 27 consecutive quarters of year-on-year cash receipt growth. The company achieved an approximate 24% compound annual growth rate in cash receipts over nearly seven years, delivered positive operating cash flow of $232,000 for 2025 after a prior deficit, maintained more than 90% of revenue as recurring, and completed the acquisition of Core Chemicals to increase exposure to the gold sector while progressing its domestic water treatment product launch, positioning the business for a forecast record 2026 calendar year.
The most recent analyst rating on (AU:DEM) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on De.mem Ltd. stock, see the AU:DEM Stock Forecast page.
De.mem Limited shareholders have overwhelmingly approved all resolutions put to a general meeting held on 22 January 2026, including the appointment of a new auditor and several share-related measures. The meeting backed the issuance of shares to director Mr Harry de Wit, ratified previous share issues connected to the acquisition of Auswater Systems Pty Ltd and Core Chemicals Pty Ltd, and confirmed a prior placement, collectively reinforcing the company’s capital structure and validating recent corporate and M&A activities with very strong proxy support.
The most recent analyst rating on (AU:DEM) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on De.mem Ltd. stock, see the AU:DEM Stock Forecast page.
De.mem Limited has issued a corrected director’s interest notice, clarifying that shares acquired by director Andreas Hendrik De Wit between 31 October and 4 November 2025 are indirectly held via nominee BNP Paribas Nominees Pty Ltd rather than directly held as previously reported. The updated disclosure, authorised by CEO Andreas Kroell, rectifies the classification error in the original Appendix 3Y lodged in November 2025, underscoring the company’s attention to accurate regulatory reporting and transparency in relation to director shareholdings.
The most recent analyst rating on (AU:DEM) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on De.mem Ltd. stock, see the AU:DEM Stock Forecast page.
De.mem Limited has issued 250,000 fully paid ordinary shares following the vesting and exercise of an equivalent number of performance rights granted under its Employee Incentive Plan, with no exercise price payable. The company has confirmed that these shares were issued without a prospectus under the relevant Corporations Act provisions and that it remains compliant with its continuous disclosure and financial reporting obligations, with no excluded information requiring disclosure, effectively cleansing the new securities for on-market trading and signalling routine capital management aligned with staff incentives.
The most recent analyst rating on (AU:DEM) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on De.mem Ltd. stock, see the AU:DEM Stock Forecast page.
De.mem Ltd has applied to the Australian Securities Exchange for quotation of 250,000 new fully paid ordinary shares, issued on 16 January 2026 under the company’s ASX code DEM. The additional shares arise from the exercise or conversion of existing options or other convertible securities, modestly increasing the company’s quoted capital base and slightly diluting existing shareholders while supporting ongoing funding and capital management activities.
The most recent analyst rating on (AU:DEM) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on De.mem Ltd. stock, see the AU:DEM Stock Forecast page.
De.mem Limited has announced the cessation of director Mr Cosimo Trimigliozzi from the board effective 31 December 2025. In his final director’s interest notice to the ASX, the company disclosed that Trimigliozzi holds 750,000 unlisted options exercisable at $0.2058 expiring on 23 May 2026 and a beneficial interest in 1,865,902 fully paid ordinary shares held via BNP Paribas Nominees Pty Ltd, with no interests in any related contracts noted, providing clarity to investors on his remaining equity position following his departure from the board.
The most recent analyst rating on (AU:DEM) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on De.mem Ltd. stock, see the AU:DEM Stock Forecast page.
De.mem Limited has called a virtual General Meeting of shareholders for 22 January 2026, to be held via a Zoom webinar, and has shifted to electronic distribution of its Notice of Meeting and explanatory materials in line with Corporations Act provisions. Shareholders are being directed to access the documents through the company’s website and ASX announcements platform, with the board strongly encouraging the early lodgement of directed proxies, underscoring the company’s move toward more digital and cost-efficient shareholder communication while maintaining engagement in a fully online meeting format.
The most recent analyst rating on (AU:DEM) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on De.mem Ltd. stock, see the AU:DEM Stock Forecast page.
De.mem has reported record financial performance over the period to H1 2025, with cash receipts rising 15% in calendar 2024 to $28.4 million and a further 16% in the first half of 2025 to $15.7 million, marking 26 consecutive quarters of growth and a compound annual growth rate of about 24% since 2019. More than 90% of revenue now comes from recurring sources such as service contracts and specialty chemicals, helping drive gross margins to a record 43% in H1 2025 from 41% in 2024 and 18% in 2017, and enabling the company to reach positive EBITDA and strong operating cash flows, which management presents as a structural inflection point in profitability and scale for shareholders.
The most recent analyst rating on (AU:DEM) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on De.mem Ltd. stock, see the AU:DEM Stock Forecast page.
De.mem Limited has issued 770,370 fully paid ordinary shares at a deemed price of $0.135 per share as consideration for services provided under an investor relations agreement. The company has confirmed that these shares were issued without a prospectus under the Corporations Act’s secondary trading provisions, that it remains compliant with its continuous disclosure and financial reporting obligations, and that there is no excluded information requiring disclosure, signalling that the administrative share issuance should not materially affect its regulatory standing or transparency to investors.
The most recent analyst rating on (AU:DEM) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on De.mem Ltd. stock, see the AU:DEM Stock Forecast page.
De.mem Ltd has applied to the ASX for quotation of 770,370 new fully paid ordinary shares, issued on 18 December 2025. The new shares are being issued in lieu of cash payment for services provided under an investor relations agreement, indicating the company’s use of equity-based compensation to manage its cash position and strengthen its market communication and investor engagement efforts.
The most recent analyst rating on (AU:DEM) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on De.mem Ltd. stock, see the AU:DEM Stock Forecast page.
De.mem Ltd. has announced the cessation of 500,000 securities due to the expiry of options or other convertible securities without exercise or conversion. This development may impact the company’s capital structure and could have implications for stakeholders regarding the company’s financial strategies and market positioning.
The most recent analyst rating on (AU:DEM) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on De.mem Ltd. stock, see the AU:DEM Stock Forecast page.
De.mem Limited has successfully closed a $500,000 shareholder loan facility to finance its acquisition of Core Chemicals Pty Ltd. This marks a strategic milestone as it is the first time De.mem has secured debt finance, made possible by its transition to positive operating cashflows and EBITDA in 2025. The loan, provided by the company’s Chairman and CFO, will support the expansion of Core Chemicals, which has already exceeded revenue expectations since its acquisition. This move is expected to bolster De.mem’s growth without equity dilution and enhance its market positioning in the booming gold mining industry.
The most recent analyst rating on (AU:DEM) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on De.mem Ltd. stock, see the AU:DEM Stock Forecast page.
De.mem Ltd has successfully integrated Core Chemicals Pty Ltd into its operations, following the acquisition completed on October 31, 2025. This integration has resulted in cost synergies and exceeded revenue expectations, with Core Chemicals generating $675k in November alone. The acquisition is expected to enhance De.mem’s market position by diversifying revenue streams and expanding customer reach beyond Western Australia, tapping into potential growth in the Eastern states and the Asia/Pacific region.
The most recent analyst rating on (AU:DEM) stock is a Hold with a A$0.11 price target. To see the full list of analyst forecasts on De.mem Ltd. stock, see the AU:DEM Stock Forecast page.
De.mem Limited has announced the appointment of Hall Chadwick Melbourne as its new auditor following the resignation of William Buck Audit (Vic) Pty Ltd., with the change being approved by ASIC. A resolution for this appointment will be proposed to shareholders at a General Meeting in early 2026. This change in auditors is part of De.mem’s ongoing efforts to maintain robust financial oversight as it continues to expand its operations in the water and wastewater treatment sector.
De.mem Ltd. announced a change in the director’s interest, specifically regarding Andreas Hendrik De Wit. The director acquired a total of 660,000 fully paid ordinary shares through on-market purchases on three separate dates. This change reflects an increase in the director’s direct interest in the company’s securities, potentially indicating confidence in the company’s future prospects.
De.mem Limited has issued 3,575,254 fully paid ordinary shares at $0.102 per share to the vendors of Core Chemicals Pty Ltd as part of its acquisition deal. This strategic move is expected to enhance De.mem’s market position by integrating Core Chemicals’ capabilities, potentially benefiting stakeholders through expanded service offerings and operational synergies.
De.mem Ltd has completed the acquisition of Core Chemicals Pty Ltd, a specialty chemicals supplier for the gold mining sector in Western Australia, for approximately $3 million. This strategic acquisition is expected to enhance De.mem’s market presence in the surging gold mining industry by providing significant revenue synergies and cross-selling opportunities. The combined entity will initially serve 33 gold mines, with plans to expand to the remaining 142 mines in Australia, and explore international growth. The acquisition positions De.mem to benefit from the ongoing bull market in gold, with the gold price recently exceeding US$4,000/ounce and forecasts predicting further increases.
De.mem Limited has reported record results for the September Quarter 2025, with cash receipts reaching approximately $7.81 million, marking the second-highest in the company’s history. The company achieved a compound annual growth rate of 24% over six years and has maintained growth momentum with 26 consecutive quarters of cash receipts growth. De.mem’s recent acquisition of Core Chemicals is expected to enhance its exposure to the gold sector and increase its proforma adjusted EBITDA. The company is on track for record results for the full calendar year 2025, with additional benefits anticipated from the acquisition.